Ardent Health Statistics
Total Valuation
Ardent Health has a market cap or net worth of $1.39 billion. The enterprise value is $3.02 billion.
| Market Cap | 1.39B |
| Enterprise Value | 3.02B |
Important Dates
The next confirmed earnings date is Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ardent Health has 143.10 million shares outstanding. The number of shares has increased by 6.56% in one year.
| Current Share Class | 143.10M |
| Shares Outstanding | 143.10M |
| Shares Change (YoY) | +6.56% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 1.63% |
| Owned by Institutions (%) | 20.54% |
| Float | 23.92M |
Valuation Ratios
The trailing PE ratio is 10.11 and the forward PE ratio is 8.67. Ardent Health's PEG ratio is 13.00.
| PE Ratio | 10.11 |
| Forward PE | 8.67 |
| PS Ratio | 0.22 |
| Forward PS | 0.21 |
| PB Ratio | 1.11 |
| P/TBV Ratio | 4.43 |
| P/FCF Ratio | 5.47 |
| P/OCF Ratio | 3.01 |
| PEG Ratio | 13.00 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.28, with an EV/FCF ratio of 11.68.
| EV / Earnings | 22.24 |
| EV / Sales | 0.48 |
| EV / EBITDA | 6.28 |
| EV / EBIT | 9.28 |
| EV / FCF | 11.68 |
Financial Position
The company has a current ratio of 1.97, with a Debt / Equity ratio of 1.38.
| Current Ratio | 1.97 |
| Quick Ratio | 1.42 |
| Debt / Equity | 1.38 |
| Debt / EBITDA | 3.12 |
| Debt / FCF | 8.96 |
| Interest Coverage | 5.90 |
Financial Efficiency
Return on equity (ROE) is 14.35% and return on invested capital (ROIC) is 7.94%.
| Return on Equity (ROE) | 14.35% |
| Return on Assets (ROA) | 3.97% |
| Return on Invested Capital (ROIC) | 7.94% |
| Return on Capital Employed (ROCE) | 7.67% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $250,966 |
| Profits Per Employee | $5,389 |
| Employee Count | 25,200 |
| Asset Turnover | 1.23 |
| Inventory Turnover | 22.75 |
Taxes
In the past 12 months, Ardent Health has paid $56.22 million in taxes.
| Income Tax | 56.22M |
| Effective Tax Rate | 19.63% |
Stock Price Statistics
The stock price has decreased by -22.44% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -22.44% |
| 50-Day Moving Average | 9.28 |
| 200-Day Moving Average | 10.79 |
| Relative Strength Index (RSI) | 55.38 |
| Average Volume (20 Days) | 332,323 |
Short Selling Information
The latest short interest is 2.93 million, so 2.05% of the outstanding shares have been sold short.
| Short Interest | 2.93M |
| Short Previous Month | 2.78M |
| Short % of Shares Out | 2.05% |
| Short % of Float | 12.27% |
| Short Ratio (days to cover) | 8.57 |
Income Statement
In the last 12 months, Ardent Health had revenue of $6.32 billion and earned $135.81 million in profits. Earnings per share was $0.96.
| Revenue | 6.32B |
| Gross Profit | 3.67B |
| Operating Income | 325.58M |
| Pretax Income | 286.36M |
| Net Income | 135.81M |
| EBITDA | 481.29M |
| EBIT | 325.58M |
| Earnings Per Share (EPS) | $0.96 |
Balance Sheet
The company has $712.49 million in cash and $2.32 billion in debt, giving a net cash position of -$1.61 billion or -$11.22 per share.
| Cash & Cash Equivalents | 712.49M |
| Total Debt | 2.32B |
| Net Cash | -1.61B |
| Net Cash Per Share | -$11.22 |
| Equity (Book Value) | 1.68B |
| Book Value Per Share | 9.01 |
| Working Capital | 1.01B |
Cash Flow
In the last 12 months, operating cash flow was $470.51 million and capital expenditures -$211.90 million, giving a free cash flow of $258.61 million.
| Operating Cash Flow | 470.51M |
| Capital Expenditures | -211.90M |
| Depreciation & Amortization | 155.70M |
| Net Borrowing | -7.42M |
| Free Cash Flow | 258.61M |
| FCF Per Share | $1.81 |
Margins
Gross margin is 57.98%, with operating and profit margins of 5.15% and 2.15%.
| Gross Margin | 57.98% |
| Operating Margin | 5.15% |
| Pretax Margin | 4.53% |
| Profit Margin | 2.15% |
| EBITDA Margin | 7.61% |
| EBIT Margin | 5.15% |
| FCF Margin | 4.09% |
Dividends & Yields
Ardent Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.56% |
| Shareholder Yield | -6.56% |
| Earnings Yield | 9.60% |
| FCF Yield | 18.27% |
Analyst Forecast
The average price target for Ardent Health is $13.20, which is 35.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.20 |
| Price Target Difference | 35.94% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ardent Health has an Altman Z-Score of 2.07 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.07 |
| Piotroski F-Score | 8 |